<DOC>
	<DOCNO>NCT00799149</DOCNO>
	<brief_summary>To determine administered part multimodal analgesic regimen , use new COX-2 antagonist etoricoxib ( 120 mg/day , per o ) effective improve postoperative pain management knee arthroscopy gabapentin ( 1.2 g/day , per o ) .</brief_summary>
	<brief_title>Etoricoxib Versus Gabapentin Knee Arthroscopy</brief_title>
	<detailed_description>Background : Post-discharge pain remain significant problem many ambulatory surgery procedure . Both etoricoxib gabapentin use prevent postoperative pain ; however relative efficacy post-discharge period know . We hypothesize daily use etoricoxib would offer advantage gabapentin part multimodal analgesic regimen perioperative period due pharmacokinetic profile . Methods : Seventy-five healthy outpatient undergo elective ambulatory knee arthroscopy randomly assign receive identical-appearing capsule contain either placebo , gabapentin ( 1.2g , etoricoxib 120 mg , 30-90 min skin incision 08H00 first , second , third postoperative day . Post-discharge pain treat `` rescue '' dipyrone syrup ( 500 mg ) . Pain intensity ( assess use 100 visual analog scale ) , dipyrone usage , incidence nausea vomiting , sedation anxiety record specific time interval postoperative period . The recovery functional activity assess 96 h surgery use validated questionnaire .</detailed_description>
	<mesh_term>Etoricoxib</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Elective ambulatory knee arthroscopy History clinicallysignificant cardiovascular , pulmonary , hepatic , renal , neurologic , psychiatric metabolic disease Patients chronically receive pain killer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Post-operative pain</keyword>
	<keyword>Knee arthroscopy</keyword>
	<keyword>Gabapentin</keyword>
	<keyword>Etoricoxib</keyword>
	<keyword>Elective ambulatory knee arthroscopy</keyword>
</DOC>